HQY (HealthEquity) GF Value : $94.33 (As of Jul. 06, 2025)

View and export this data going back to 2014. Start your Free Trial

What is HealthEquity GF Value?

As of today (2025-07-06), HealthEquity's share price is $102.16. HealthEquity's GF Value is $94.33. Therefore, HealthEquity's Price-to-GF-Value for today is 1.08. Based on the relationship between the current stock price and the GF Value, GuruFocus believes HealthEquity is Fairly Valued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

HealthEquity (NAS:HQY) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

HealthEquity's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	102.16	/	94.33
	=	1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity GF Value Related Terms

Thank you for viewing the detailed overview of HealthEquity's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthEquity Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

HQY:Mexico 2HE:Germany

Address

15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website

https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Executives

Robert W Selander	director	MASTERCARD INTERNATIONAL, 2000 PURCHASE STREET, PURCHASE NY 10577
Stuart B. Parker	director	200 EAST RANDOLPH STREET, SUITE 3300, CHICAGO IL 60601
Elimelech Rosner	officer: EVP, Chief Technology Officer	5196 BELMORE COURT, SUWANEE GA 30024
Debra Charlotte Mccowan	director	1436 CABRILLO AVENUE, BURLINGAME CA 94010
Frank Corvino	director	GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Jon Kessler	director, officer: President and CEO	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Stephen Neeleman	director, officer: Founder and Vice Chairman	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Gayle Furgurson Wellborn	director	123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Evelyn S Dilsaver	director	C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596
Delano Ladd	officer: Executive VP, GC & Corp. Secy.	15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks	director	TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Tyson D. Murdock	officer: EVP & CFO	2275 S. 2200 E., SALT LAKE CITY UT 84109
Larry L Trittschuh	officer: EVP Chief Security Officer	1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania	officer: EVP & CFO	101 WOLF DRIVE, THOROFARE NJ 08086
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184